已收盤 02-06 16:00:00 美东时间
+1.670
+3.27%
今日重点评级关注:康托·菲茨杰拉德:维持Wave Life Sciences Ltd."超配"评级,目标价从34美元升至41美元;Piper Sandler:维持Replimune Group"超配"评级,目标价从13美元升至14美元
02-06 16:52
华盛资讯2月4日讯,Zurn Elkay Water Solutions Corporation公布2025财年Q4业绩,公司Q4营收4.07亿美元,同比增长9.8%,归母净利润0.42亿美元,同比增长15.7%。
02-04 15:17
The Q4 earnings report for Zurn Elkay Water Solns (NYSE:ZWS) was released on Tu...
02-04 05:24
Zurn Elkay posts Q4 net sales of USD 407 million, up 10% Zurn Elkay Water Solutions Corporation (NYSE: ZWS) reported its financial results for the fourth quarter (Q4) and full year (FY) 2025. In Q4 2025, net sales were USD 407 million, representing a 10% increase in core sales. Net income from conti
02-04 05:06
Companies Reporting Before The Bell • Atkore (NYSE:ATKR) is expected to report ...
02-03 19:11
Zurn Elkay Water (NYSE:ZWS) is gearing up to announce its quarterly earnings on...
02-03 03:01
Zurn Elkay Water (NYSE:ZWS) is gearing up to announce its quarterly earnings on...
02-03 03:01
Zurn Elkay Water Solutions Declares $0.11 Quarterly Dividend Zurn Elkay Water Solutions Corporation has declared a quarterly cash dividend of $0.11 per share, payable on March 6, 2026, to shareholders of record as of February 20, 2026. Disclaimer: This news brief was created by Public Technologies (
01-30 01:33
Zurn Elkay Water Solutions Corporation published an update to their financial calendar Zurn Elkay Water Solutions Corporation will release its fourth quarter and full year 2025 financial results after market close on Tuesday, February 3, 2026. Results will be available on the Company's investor rela
01-22 05:06
今日重点评级关注:HC Wainwright & Co.:维持Assertio Holdings"买入"评级,目标价从3美元升至35美元;HC Wainwright & Co.:维持万达生物制药"买入"评级,目标价从20美元升至22美元
01-06 17:52